Ultime notizie per KalVista Pharma (NASDAQ:KALV) Azioni

KALVISTA PHARMACEUTICALS INC

KalVista Pharma

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharmaceuticals Inc

News

Offerings

Viking Holdings Launches Secondary Offering Of 30,531,917 Ordinary Shares By Certain Selling Shareholders

A majority of Americans are ready to light up, not just in lounges or at home but also in the heart of casino resorts.
A new <a href="https://www.unlv.edu/president/initiatives/cannabis-policy-institute">survey</a> from the Cannabis Policy Institute at the University of Nevada Las Vegas found that 70% of respondents support allowing cannabis use in casino resorts, either through designated lounges or smoking areas. The findings arrive amid renewed debate over Nevada&#8217;s legal separation between gaming and cannabis, a firewall increasingly seen as outdated by both industries.
<h3 class="wp-block-heading">What The Data Shows</h3>
The CPI study surveyed 620 U.S. adults over the age of 21. Key takeaways:
<ul class="wp-block-list">
<li>70% support some form of cannabis consumption at casino resorts.</li>
<li>68% favor having cannabis-smoking rooms in hotels, similar to tobacco-smoking rooms.</li>
<li>40% said they would be more likely to gamble at a resort that allowed cannabis use.</li>
<li>58% said their gambling behavior would not change with cannabis consumption.</li>
<li>25% said they would gamble more; 18% said less.</li>
</ul>
Roughly a third of respondents admitted to having consumed cannabis while gambling, mostly "less than half the time." Even so, two-thirds said they had never combined the two activities.
The study, characterized by researchers as exploratory, was designed to inform a broader discussion about whether evolving public opinion—and the rise of cannabis tourism—warrants a policy shift in Nevada's regulatory approach.
<h3 class="wp-block-heading">What&#8217;s At Stake In Las Vegas</h3>
Cannabis consumption is legal in Nevada, but state law prohibits its use in casinos or related properties. The CPI report, produced in conjunction with Assembly Bill 203, urges a formal dialogue between the Nevada Gaming Control Board and the state's Cannabis Compliance Board.
One rationale for the firewall has been a presumed risk that cannabis use might reduce gambling activity. The CPI found no supporting data for this assumption, suggesting instead that further research is needed to fully understand behavioral correlations.
If legislative and regulatory frameworks evolve, Nevada could become a pioneer in integrating cannabis into its hospitality sector, potentially reshaping Las Vegas as a global destination for cannabis-friendly entertainment.
<h3 class="wp-block-heading">Public Companies With A Stake</h3>
Cannabis Operators
Planet 13 Holdings (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTCQX">PLNHF</a>)
<ul class="wp-block-list">
<li>Operates 112,000 sq ft cannabis superstore near the Vegas Strip</li>
<li>Opened the first public state-licensed consumption lounge: Dazed!</li>
<li>Generated $28M in Q1 2025 revenue</li>
</ul>
Curaleaf Holdings (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>)
<ul class="wp-block-list">
<li>Owns dispensaries in Las Vegas and northern Nevada (via Tryke)</li>
<li>Received a conditional license for a lounge near the Strip</li>
<li>Expanding footprint in Nevada cannabis hospitality</li>
</ul>
Verano Holdings (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTCQX">VRNOF</a>)
<ul class="wp-block-list">
<li>Acquired Sierra Well with dispensaries and facilities in Reno and Carson City</li>
<li>No lounge yet, but strong infrastructure for future entry</li>
<li>Active in multistate markets with a focus on vertical integration</li>
</ul>
Casino Operators
<ul class="wp-block-list">
<li>MGM Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>), Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) and Wynn Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>): These Strip giants stand to gain the most from regulatory reform and cannabis-tourist engagement.</li>
<li>Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) and Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>): Potential indirect beneficiaries, particularly if cannabis lounges increase tourism volume.</li>
</ul>
<h3 class="wp-block-heading">What&#8217;s Next?</h3>
Nevada lawmakers are expected to consider the CPI&#8217;s findings alongside AB203, which mandates academic input into future cannabis-gaming regulations.
Meanwhile, the disconnect between law and consumer behavior is already playing out: cannabis remains banned on the Strip, but illicit delivery persists. A regulated system could enhance safety, drive tax revenue, and reflect evolving public sentiment.
Photo: Shutterstock

Cannabis

Gaming

Sports Betting

Travel

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

PLNHF

TCNNF

VRNOF

WYNN

Could Marijuana-Friendly Casinos Be Las Vegas' Next Big Jackpot? 70% Of Americans Say 'You Bet'

'GM To Invest $880M For Engine Production At New York Facility, Sources Say'

WIIM

NFGC

New Found Gold Corp shares are trading higher after the company announced it entered into a bought deal charity flow-through offering to generate proceeds of approximately C$49 million and stated plans for a C$20 million private placement.

Maturities extended into 2030
Facilities maintain favorable pricing and terms
LAKE OSWEGO, Ore., May 27, 2025 /PRNewswire/ -- The Greenbrier Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) ("Greenbrier"), a leading international supplier of equipment and services to global freight transportation markets, today announced the renewal and extension of two bank facilities totaling $850 million completed on May 21, 2025. Greenbrier renewed its $600 million domestic revolving facility and $250 million term loan, with favorable pricing and terms, extending both instruments by five years until 2030. With this activity completed, remaining long-term debt maturities are staggered into 2030, with the next significant debt tranche maturing in 2027.

Greenbrier Companies Renews $600M Domestic Revolving Facility And $250M Term Loan, With Favorable Pricing And Terms, Extending Both Instruments By Five Years Until 2030

Revenues (net financial income + net fee income – turnover tax) totaledAR$206.9 billion in 1Q25, compared to AR$477.2 billion in 1Q24 and AR$232.9 billion in 4Q24.

Earnings

SUPV

Grupo Supervielle Reports Q1 2025 Revenue Of AR$206.9 Billion

Semtech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) shares are moving lower in Tuesday&#8217;s after-hours session on the heels of the company&#8217;s first-quarter results. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45630236/semtech-announces-first-quarter-of-fiscal-year-2026-results">of the report</a>.
<ul class="wp-block-list">
<li>Q1 Revenue: $251.1 million, versus <a href="http://benzinga.com/quote/SMTC/earnings">estimates</a> of $250.09 million</li>
</ul>
<ul class="wp-block-list">
<li>Q1 Adjusted EPS: 38 cents, versus estimates of 37 cents</li>
</ul>
Total revenue was up 22% year-over-year in the first quarter. The semiconductor, IoT systems and cloud connectivity service provider reported GAAP gross margin of 52.3%, up from 48.3% in the prior year&#8217;s quarter. 
Semtech ended the period with $156.5 million in cash and cash equivalents. 
&#8220;I am pleased with our solid first quarter results that reflected improving demand trends, strong business fundamentals and disciplined execution in a dynamic environment,&#8221; said Hong Hou, president and CEO of Semtech.
&#8220;At the same time, we continue investing strategically in innovation, go-to-market capabilities, and operational scale — laying a strong foundation for sustained growth and long-term value creation.&#8221;
Outlook: Semtech expects second-quarter revenue of $256 million, plus or minus $5 million, versus estimates of $255.55 million. The company anticipates second-quarter adjusted earnings of 40 cents per share, plus or minus three cents per share, versus <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates of 39 cents per share.
Semtech executives will further discuss the quarter on a conference call with investors and analysts at 4:30 p.m. ET.
SMTC Price Action: <a href="http://benzinga.com/quote/SMTC">Semtech shares</a> were down 2.40% in after-hours, trading at $37.85 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45629981/nvidia-amd-shares-climb-as-tariff-delay-boosts-tech-sector-whats-going-on">NVIDIA, AMD Shares Climb As Tariff Delay Boosts Tech Sector: What&#8217;s Going On?</a></li>
</ul>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45630958/okta-beats-q1-earnings-estimates-shares-tumble-on-cautious-guidance-commentary">Okta Beats Q1 Earnings Estimates, Shares Tumble On Cautious Guidance Commentary</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/MichaelVi">Michael Vi</a>/Shutterstock.

Guidance

Movers

SMTC

Semtech Stock Slides On Q1 Earnings: Key Details From The Quarter

CenterPoint Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) or "CenterPoint" today announced the commencement of a registered underwritten offering of $800,000,000 of shares of its common stock. Subject to certain conditions, all shares are expected to be borrowed by the forward counterparties (as defined below) (or their respective affiliates) from third parties and sold to the underwriters and offered in connection with the forward sale agreements described below. BofA Securities, Mizuho and J.P. Morgan are acting as joint book-running managers and representatives for the offering. Barclays, Citigroup and RBC Capital Markets are also acting as joint book-running managers for the offering.
In connection with the offering, CenterPoint expects to enter into separate forward sale agreements with Bank of America, N.A., Mizuho Markets Americas LLC and JPMorgan Chase Bank, National Association (collectively, the "forward counterparties") under which CenterPoint will agree to issue and sell shares of its common stock to the forward counterparties at an initial forward sale price per share equal to the price per share at which the underwriters purchase the shares in the offering, subject to certain adjustments, upon physical settlement of the forward sale agreements. In addition, the underwriters of the offering expect to be granted a 30-day option to purchase up to an additional $120,000,000 of shares of CenterPoint's common stock upon the same terms. If the underwriters exercise all or a portion of their option to purchase additional shares, CenterPoint expects to enter into additional forward sale agreements with the forward counterparties with respect to the additional shares.
Settlement of the forward sale agreements is expected to occur on or prior to February 25, 2027. CenterPoint may, subject to certain conditions, elect cash settlement or net share settlement for all or a portion of its rights or obligations under each of the forward sale agreements.
If CenterPoint elects physical settlement of the forward sale agreements, it expects to use the net proceeds for general corporate purposes, which may include repayment of commercial paper or other debt.
The offering is being made pursuant to CenterPoint's effective shelf registration statement filed with the U.S. Securities and Exchange Commission (the "SEC"). The preliminary prospectus supplement and the accompanying base prospectus related to the offering will be available on the SEC's website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sec.gov%2F&amp;esheet=54261033&amp;newsitemid=20250527067364&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=1&amp;md5=ba4c6d48068a8aeb0dbd9ac1574ee1b3">www.sec.gov</a>. Copies of the preliminary prospectus supplement and the accompanying base prospectus relating to the offering may be obtained from the joint book-running managers for the offering as follows:

Centerpoint Energy Announces Registered Underwritten Offering Of $800M of Shares of Its Common Stock

New Found Gold Corp. ("New Found Gold" or the "Company")(TSXV:<a class="ticker" href="https://www.benzinga.com/stock/NFG#TSXV">NFG</a>, NYSE-A: NFGC))) has announced today that it has entered into an agreement with BMO Capital Markets and SCP Resource Finance LP, on behalf of themselves and a syndicate of underwriters (collectively, the "Underwriters") led by BMO Capital Markets and SCP Resource Finance LP, under which the Underwriters have agreed to buy, on a bought deal basis, 21,400,000 charity flow-through common shares of the Company (the "Charity Flow-Through Common Shares") at a price of C$2.29 per Charity Flow-Through Common Share for aggregate gross proceeds of approximately C$49 million (the "Offering"). The Company has granted the Underwriters an option, exercisable at the offering price up to 30 days following the closing of the Tranche 1 (as defined below), to purchase up to an additional 15% of the Charity Flow-Through Common Shares issued in connection with the Offering. Each Charity Flow-Through Common Share will qualify as a "flow-through share" within the meaning of subsection 66(15) of the Income Tax Act (Canada).
Subsequent to the Offering, the Company also expects to complete a non-brokered private placement of up to 12,269,939 non-flow-through common shares (the "Common Shares") at a price of C$1.63 per Common Share of the Company for gross proceeds of approximately C$20 million (the "Private Placement" and, together with the Offering, the "Financing"). The Common Shares issued pursuant to the Private Placement will be subject to a statutory hold period of 4 months and one day. The Private Placement is subject to the Company receiving all necessary approvals, including shareholder approval and the approval of the TSX Venture Exchange (the "TSXV") and authorization of the NYSE American LLC (the "NYSE American").

Buybacks

TSXV:NFG

New Found Gold Announces C$49M Bought Deal Offering Of 21.4M Charity Flow-Through Shares At C$2.29, And Plans Additional C$20M Non-Brokered Private Placement Of 12.27M Common Shares At C$1.63 Per Share

E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) (the "Company" or "E-Home"), a provider of integrated household services in China, today announced that at an extraordinary general meeting of the Company held on May 1, 2025 (the "Meeting"), its shareholders have approved the resolution of a share consolidation of the issued and authorized ordinary shares of the Company at a ratio of not less than one (1)-for-two (2) and not more than one (1)-for-fifty (50) (the "Range"), with the exact ratio to be set at a whole number within this Range to be determined by the Board of the Directors of the Company (the "Board") in its sole discretion within 180 calendar days after the date of passing of these resolutions (the "Share Consolidation").

E-Home Household Service Approves Share Consolidation, Ratio Set Between 1-For-2 And 1-For-50

General

On May 20, General Mills Approved Multi-Year Global Transformation Initiative; Transformation Initiative To Result In $130M Total Charges

CMBM

Cambium Networks Receives Noncompliance Notice From Nasdaq

TransAlta Corporation ("TransAlta" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) announced today that the Toronto Stock Exchange ("TSX") has accepted the notice filed by the Company to implement a normal course issuer bid ("NCIB") for a portion of its common shares ("Common Shares").
Pursuant to the NCIB, TransAlta may repurchase up to a maximum of 14,000,000 Common Shares, representing approximately 4.7% of the 296,449,829 Common Shares issued and outstanding as at May 20, 2025. Purchases under the NCIB may be made through open market transactions on the TSX and any alternative Canadian trading systems on which the Common Shares are traded, based on the prevailing market price. Any Common Shares purchased under the NCIB will be cancelled.

TSX:TA

TransAlta Announces TSX Approval For Normal Course Issuer Bid To Repurchase Up To 14M Common Shares, Representing 4.7% Of Outstanding Shares, With All Repurchased Shares To Be Cancelled

Fortive Increases Number Of Shares Authorized Under General Share Repurchase Program By ~15.63M Additional Shares; Co. Also Announces Adoption Of A Separate Special Purpose Share Repurchase Authorization To Deploy Up To $550M From Cash Distribution From Ralliant Corporation

MAIA Biotechnology, Inc., (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#NYSE">MAIA</a>) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 446,332 shares of common stock at a purchase price of $1.50 per share, in a private placement to accredited investors and a Company director. Each share of common stock is being offered together with a warrant to purchase one share of common stock at an exercise price of $1.71 per share, which price represents the greater of the book or market value of the stock on the date the definitive agreements were executed (subject to customary adjustments as set forth in the warrants). The warrants are exercisable commencing six-months following issuance and have a term of five years from the initial issuance date. The securities being sold to the Company director participating in the offering are being issued pursuant to the Company's 2021 Equity Incentive Plan. The private placement is expected to close on or about May 29, 2025, subject to the satisfaction of customary closing conditions.
The gross proceeds from the offering are expected to be approximately $669,500, prior to offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for to fund the execution of Step 1 of Part C of the Phase II trial THIO -101 and for working capital.

MAIA

MAIA Biotechnology Announces Private Placement of 446,332 Shares At $1.50/Shr

Slash, the neo-bank launched by college dropouts Victor Cardenas and Kevin Bai, <a href="https://www.slash.com/blog/slash-raises-series-b">announced</a> Tuesday it has closed a fresh $41 million funding round at a $370 million valuation, which was led by Goodwater Capital and supported by Menlo Ventures and New Enterprise Associates.
The raise marks a definitive comeback after the company's core market, sneaker resellers, collapsed overnight, following Adidas' decision to end its collaboration with <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43879013/after-im-a-nazi-rant-on-x-kanye-west-is-reportedly-considering-a-token-after-all">Kanye West</a>,<a href="https://fortune.com/article/slash-vertical-banking-nea-fintech-tech-funding-performance-marketing/"> Fortune</a> reports.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Slash Went From Yeezys to Vertical Fintech</h2>
The idea for Slash emerged while Cardenas was studying at Stanford University and Bai at the University of Waterloo in Canada, Fortune says. As they explored different startup concepts, they discovered an ecosystem of sneaker resellers: young entrepreneurs generating substantial revenue but struggling to access essential banking tools. Many lacked incorporation or were too young to qualify for products like virtual credit cards, exposing a clear gap in the market.&nbsp;
According to Fortune, that niche allowed the startup to quickly gain traction, especially as it offered virtual cards and other tools tailored to their needs. But when <a href="https://www.benzinga.com/markets/25/05/45195137/footwear-titans-nike-adidas-call-tariffs-an-existential-threat-appeal-to-trump-for-relief-this-is-an-emergency">Adidas</a> cut ties with Kanye West, the Yeezy resale economy collapsed. Slash saw its revenue fall by 80% almost instantly.
The founders had<a href="https://www.slash.com/blog/announcing-slashs-dollar19m-seed-and-series-a"> announced</a> on May 4 that they raised $19 million in earlier rounds, with dozens of employees onboard. According to Fortune, they faced a decision: double down on a dying niche or rebuild from scratch.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a>
Over the next 18 months, they chose to rebuild from scratch, transforming Slash into a vertical banking engine for underserved industries like crypto firms, HVAC companies, and performance marketing agencies, to name a few. Today, Slash processes roughly $300 million each month through its cards, Fortune reports.
<h2 class="wp-block-heading">A Startup Betting on the Power of Verticalization</h2>
While competitors like Brex, Mercury, and Ramp spread their services across industries, Slash doubled down on vertical integration. Fortune says that the founders&#8217; approach is to design bespoke banking infrastructure for the unique workflows of specific sectors.
In performance marketing, that means creating sub-accounts for each client so agencies can track ad spending and prepayment balances. In crypto, Slash enables companies to move between fiat and digital currencies while maintaining transparent internal finance systems. More than 1% of all Facebook ads are now purchased through Slash-issued cards, Fortune reports.
"If we continue solving these niche, vertical, specific financial workflows for businesses across different industries, then we can sneakily become one of the largest commercial credit card issuers in the country," Cardenas told Fortune.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Institutional Backing and Strategic Growth</h2>
According to a LinkedIn<a href="https://www.linkedin.com/posts/joinslash_thrilled-to-announce-our-41-million-series-activity-7330643489958830081-x9wN/"> post</a>, Goodwater Capital leads the new round, with NEA returning as a consistent backer since Slash's early stages. Other notable investors include figures like Joshua Browder of DoNotPay and Zach Abrams.
According to Fortune, the startup also has support from Column, a tech-friendly chartered bank co-founded by a Plaid executive. Their partnership helped Slash navigate the recent turmoil around fintech infrastructure provider Synapse, which disrupted operations for many competitors.
The current 35-person team plans to use the new capital to scale into more verticals, including online travel, property management, and e-commerce, Fortune says. As Slash continues to solve critical pain points in niche industries, it quietly positions itself as one of the fastest-growing commercial credit card issuers in the U.S.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Two College Dropouts Secured $41 Million To Revolutionize Industry-Specific Banking With Slash, Backed By Top VCs

Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) has outperformed the market over the past 10 years by 5.27% on an annualized basis producing an average annual return of 16.1%. Currently, Domino's Pizza has a market capitalization of $16.59 billion. 
Buying $100 In DPZ: If an investor had bought $100 of DPZ stock 10 years ago, it would be worth $444.35 today based on a price of $484.56 for DPZ at the time of writing.
<h3>Domino's Pizza's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748377812_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Domino's Pizza 10 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MPXOF">MPX International</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPXOF#OTC">MPXOF</a>) shares closed up 9900.00% at $0.0001</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 9.08% at $0.28</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 8.26% at $1.18</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 7.54% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 7.03% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 5.49% at $0.35</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.87% at $1.67</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 25.41% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 18.52% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 10.34% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 10.14% at $0.81</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed down 10.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 8.05% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 6.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 5.46% at $1.70</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 5.00% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 4.55% at $0.89</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.30% at $4.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 3.64% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 3.23% at $1.20</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.20% at $0.15</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Markets

CBDY

CNBX

CNTMF

CXXIF

FUAPF

GNLN

GRWG

ITHUF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

MGWFF

MPXOF

MRMD

NWVCF

TGIFF

UGRO

XXII

Cannabis Stock Movers For May 27, 2025

Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/05/b45630231/box-reports-first-quarter-fiscal-2026-financial-results">from the report. </a>
The Details: Box reported quarterly earnings of 30 cents per share, which beat the Street estimate of 26 cents. Quarterly revenue came in at $276 million, which beat the consensus estimate of $274.8 million and is an increase over revenue of $264.66 million from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/legal/25/05/45568107/solar-energy-stocks-drop-as-house-approves-major-rollback-of-climate-incentives?utm_source=article">Solar Energy Stocks Drop As House Approves Major Rollback Of Climate Incentives</a>
For the first quarter, Box reported: 
<div class="wp-block-group is-layout-constrained wp-block-group-is-layout-constrained">
<ul class="wp-block-list">
<li>Remaining Performance Obligations of $1.469 billion, up 21% Year-Over-Year, or 17% on a constant currency basis. </li>
<li>Billings of $242.3 million, up 27%, or 17% on a constant currency basis.</li>
<li>Non-GAAP gross profit of $222.3 million, or 80.5% of revenue, up from $212.2 million, or 80.2% of revenue.</li>
</ul>
&#8220;We are at a pivotal moment in history where AI is revolutionizing work and business,&#8221; said Aaron Levie, CEO of Box. 
&#8220;In this AI-first era, organizations are embracing this shift to stay competitive. At Box, we help businesses unlock value from their unstructured data with our Intelligent Content Management platform,&#8221; Levie added.
</div>
<h1 class="wp-block-heading">Box Stock Prediction 2025</h1>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Box have an average 1-year price target of $36, representing an expected upside of 14.39%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. One analyst has a bearish recommendation on Box, while four analysts have bullish ratings. The street high price target from DA Davidson is $45, while the street low from RBC Capital is $21.
BOX Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Box stock was up 10.84% at $34.86 in Tuesday's extended trading.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/mid-cap/25/05/45587750/uranium-stocks-surge-trumps-nuclear-push-sparks-double-digit-gains?utm_source=articleShare">Uranium Stocks Surge: Trump&#8217;s Nuclear Push Sparks Double-Digit Gains</a>&nbsp;</li>
</ul>
Photo: Shutterstock

After-Hours Center

Tech

Box Stock Rallies After Better-Than-Expected Q1 Results: Details

<ul>
<li>Expected separation completion date of June 28, 2025</li>
<li>Record date for distribution of Ralliant common stock will be June 16, 2025</li>
<li>"When-issued" trading of Ralliant common stock expected to begin on June 25, 2025</li>
<li>Ralliant to host an investor day conference on June 10, 2025</li>
</ul>
Fortive Corporation ("Fortive") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) today announced that its Board of Directors has declared a pro rata dividend of 100% of the outstanding common stock of Ralliant Corporation ("Ralliant") to Fortive's shareholders of record as of the close of business on June 16, 2025 (the "Record Date"). The dividend is payable at 12:01 a.m. ET on June 28, 2025 ("Distribution Date") with Fortive shareholders receiving one share of Ralliant common stock for every three shares of Fortive common stock they hold on the Record Date. Fortive shareholders will receive cash in lieu of any fractional shares of our common stock that they would have received after application of this ratio.

Dividends

Fortive Sets June 28, 2025 For Completion Of Ralliant Spin-Off; Shareholders to Receive 1 Ralliant Share For Every 3 Fortive Shares Held As Of June 16 Record Date, With "When-Issued" Trading to Begin June 25

Press Releases

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema

KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update

KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

KalVista Pharmaceuticals to Present at 24th Annual Needham Virtual Healthcare Conference

KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan

KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference

KalVista Pharmaceuticals to Present New Sebetralstat Data With 10 Abstracts Accepted at Upcoming Medical Meetings

Comments

KalVista Pharma

Notizie

Ultime notizie per KalVista Pharma (NASDAQ:KALV) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO